Literature DB >> 30815749

Recent Advances in Congenital Heart Surgery: Alternative Perfusion Strategies for Infant Aortic Arch Repair.

Andrew J Lodge1, Nicholas D Andersen2, Joseph W Turek2.   

Abstract

PURPOSE OF REVIEW: This paper will discuss current cannulation strategies for infant aortic arch repair and compare them to more traditionally used techniques. RECENT
FINDINGS: Aortic arch reconstruction in infants has traditionally involved deep hypothermic circulatory arrest which results in total body ischemia. This has been associated with an increased risk of morbidity including bleeding, renal dysfunction, and neurologic injury. Advances in perfusion techniques have allowed for preserved perfusion to the brain during arch repair. Current techniques have further evolved that allow for continuous perfusion of the heart and even the lower body during arch reconstruction. With current techniques, aortic arch reconstruction in infants can be performed with continuous perfusion to the brain, heart, and lower body. Further technical refinements will be helpful, and study is necessary to evaluate the benefit of these strategies.

Entities:  

Keywords:  Aortic arch; Cardiopulmonary bypass; Congenital heart surgery; Infant; Perfusion

Mesh:

Year:  2019        PMID: 30815749     DOI: 10.1007/s11886-019-1098-8

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


  3 in total

1.  In Vitro Evaluation of Flow Distribution in All-Region Perfusion during the Norwood Operation.

Authors:  Travis Siffring; Neel Prabhu; Gregory Smigla; David Kaemmer
Journal:  J Extra Corpor Technol       Date:  2020-12

2.  Commentary: Help a sister out: Dual cannulation strategy for neonatal heart surgery in a conjoined twin.

Authors:  Douglas M Overbey; Joseph W Turek; Nicholas D Andersen
Journal:  JTCVS Tech       Date:  2020-05-04

3.  Commentary: On aortic uncrossing: New variation on an old controversy.

Authors:  Reilly Hobbs; Ming-Sing Si
Journal:  JTCVS Tech       Date:  2020-11-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.